Less NMDA Receptor Binding in Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex Associated With Reported Early-Life Adversity but Not Suicide
暂无分享,去创建一个
V. Arango | J. Mann | M. Underwood | S. Ellis | S. Kassir | M. Bakalian | Virginia L Johnson | J. Mann
[1] P. Courtet,et al. Childhood maltreatment and risk for suicide attempts in major depression: a sex-specific approach , 2019, European journal of psychotraumatology.
[2] J. Mann,et al. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. , 2017, The American journal of psychiatry.
[3] G. Turecki,et al. Neuropathology of suicide: recent findings and future directions , 2017, Molecular Psychiatry.
[4] T. Ehring,et al. Childhood maltreatment and characteristics of adult depression: Meta-analysis , 2017, British Journal of Psychiatry.
[5] J. Savitz,et al. Neuropathology of mood disorders: do we see the stigmata of inflammation? , 2016, Translational psychiatry.
[6] Runa Bhaumik,et al. Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients , 2016, Psychiatry Research.
[7] B. Dean,et al. Changes in cortical N-methyl-d-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide , 2016, The Australian and New Zealand journal of psychiatry.
[8] W. Goodman,et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial , 2015, Psychological Medicine.
[9] M. Pompili,et al. NMDA receptor antagonists for depression: Critical considerations. , 2015, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[10] J. Krystal,et al. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. , 2015, Annual review of medicine.
[11] F. Perera,et al. DNA methylation of BDNF as a biomarker of early-life adversity , 2014, Proceedings of the National Academy of Sciences.
[12] M. Furey,et al. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. , 2014, Journal of psychiatric research.
[13] M. Szyf,et al. The Consequences of Early‐Life Adversity: Neurobiological, Behavioural and Epigenetic Adaptations , 2014, Journal of neuroendocrinology.
[14] D. de Leo,et al. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression. , 2014, The Australian and New Zealand journal of psychiatry.
[15] D. Luckenbaugh,et al. Clinical predictors of ketamine response in treatment-resistant major depression. , 2014, The Journal of clinical psychiatry.
[16] D. Charney,et al. EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT‐RESISTANT DEPRESSION , 2014, Depression and anxiety.
[17] R. Dantzer,et al. Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? , 2014, Journal of Neural Transmission.
[18] J. Lambert,et al. Dysfunctional Astrocytic and Synaptic Regulation of Hypothalamic Glutamatergic Transmission in a Mouse Model of Early-Life Adversity: Relevance to Neurosteroids and Programming of the Stress Response , 2013, The Journal of Neuroscience.
[19] A. Biegon,et al. Hippocampal Glutamate NMDA Receptor Loss Tracks Progression in Alzheimer’s Disease: Quantitative Autoradiography in Postmortem Human Brain , 2013, PLoS ONE.
[20] J. Vetulani. Early maternal separation: a rodent model of depression and a prevailing human condition , 2013, Pharmacological reports : PR.
[21] G. Pandey. Biological basis of suicide and suicidal behavior , 2013, Bipolar disorders.
[22] Teresa A. Victor,et al. Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities , 2013, Brain, Behavior, and Immunity.
[23] P. Honsa,et al. Send Orders of Reprints at Reprints@benthamscience.net Nmda Receptors in Glial Cells: Pending Questions , 2022 .
[24] S. Andersen,et al. Evidence for a neuroinflammatory mechanism in delayed effects of early life adversity in rats: Relationship to cortical NMDA receptor expression , 2013, Brain, Behavior, and Immunity.
[25] Kelly A. Bordner,et al. Maternal separation with early weaning: A rodent model providing novel insights into neglect associated developmental deficits , 2012, Development and Psychopathology.
[26] G. Laje,et al. Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression , 2012, Biological Psychiatry.
[27] Victoria Arango,et al. Neuron density and serotonin receptor binding in prefrontal cortex in suicide. , 2012, The international journal of neuropsychopharmacology.
[28] E. Kavalali,et al. NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses , 2011, Nature.
[29] A. Mallinger,et al. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[30] Nanxin Li,et al. Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure , 2011, Biological Psychiatry.
[31] Dost Öngür,et al. Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders , 2010, Biological Psychiatry.
[32] R. Dingledine,et al. Glutamate Receptor Ion Channels: Structure, Regulation, and Function , 2010, Pharmacological Reviews.
[33] C. Andrade,et al. Innovative approaches to treatment - refractory depression: The ketamine story , 2010, Indian journal of psychiatry.
[34] P. Skolnick,et al. Glutamate-based antidepressants: 20 years on. , 2009, Trends in pharmacological sciences.
[35] D. Charney,et al. Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression , 2009, Biological Psychiatry.
[36] R. Anwyl,et al. Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. , 2009, The international journal of neuropsychopharmacology.
[37] J. Krystal,et al. The NMDA receptor as a therapeutic target in major depressive disorder. , 2007, CNS & neurological disorders drug targets.
[38] P. Paoletti,et al. NMDA receptor subunits: function and pharmacology. , 2007, Current opinion in pharmacology.
[39] Paul J Carlson,et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.
[40] H. MacMillan,et al. The relationship between childhood physical abuse and suicidality among depressed women: results from a community sample. , 2003, The American journal of psychiatry.
[41] Victoria Arango,et al. Serotonin 1A Receptors, Serotonin Transporter Binding and Serotonin Transporter mRNA Expression in the Brainstem of Depressed Suicide Victims , 2001, Neuropsychopharmacology.
[42] B. Meldrum,et al. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. , 2000, The Journal of nutrition.
[43] John H Krystal,et al. Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.
[44] J. Johnson,et al. Childhood abuse and neglect: specificity of effects on adolescent and young adult depression and suicidality. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[45] P. Barbaresi,et al. Neuronal and glial localization of NR1 and NR2A/B subunits of the NMDA receptor in the human cerebral cortex. , 1999, Cerebral cortex.
[46] R. Dingledine,et al. The glutamate receptor ion channels. , 1999, Pharmacological reviews.
[47] J. Kleinman,et al. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains , 1997, Synapse.
[48] Anil K Malhotra,et al. Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.
[49] F. Conti. Localization of NMDA receptors in the cerebral cortex: a schematic overview. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[50] T. Kelly,et al. Validity of DSM‐III‐R diagnosis by psychological autopsy: a comparison with clinician ante‐mortem diagnosis , 1996, Acta psychiatrica Scandinavica.
[51] S. Lipton,et al. NMDA receptors: from genes to channels. , 1996, Trends in pharmacological sciences.
[52] J. John Mann,et al. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.
[53] G. Westbrook,et al. Kinetics of AP5 dissociation from NMDA receptors: evidence for two identical cooperative binding sites. , 1994, Journal of neurophysiology.
[54] C. Katona,et al. NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides , 1993, Brain Research.
[55] K. Frei,et al. Macrophage‐induced cytotoxicity of N‐methyl‐D‐aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines , 1992, European journal of immunology.
[56] J. D. Clements,et al. Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor , 1991, Neuron.
[57] M. Mayer,et al. Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine. , 1991, Biophysical journal.
[58] Edythe D. London,et al. Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia , 1991, Biological Psychiatry.
[59] V. Arango,et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.
[60] R. Dingledine,et al. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. , 1988, Science.
[61] P. Ascher,et al. Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.
[62] G. Acosta. Early Life Experience, Maternal Separation, and Involvement of GABA and Glutamate Transporters , 2018 .
[63] V. Arango,et al. Similar effects of glycine, zinc and an oxidizing agent on [3H]dizocilpine binding to the N-methyl-D-aspartate receptor in neocortical tissue from suicide victims and controls , 2005, Journal of Neural Transmission / General Section JNT.
[64] J. Feldon,et al. Long-term Biobehavioral Effects of Maternal Separation in the Rat: Consistent or Confusing? , 2000, Reviews in the neurosciences.
[65] D. Bernstein,et al. Childhood Trauma Questionnaire: A retrospective self-report , 1998 .